CN103073636A - Dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications thereof - Google Patents

Dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications thereof Download PDF

Info

Publication number
CN103073636A
CN103073636A CN2013100342095A CN201310034209A CN103073636A CN 103073636 A CN103073636 A CN 103073636A CN 2013100342095 A CN2013100342095 A CN 2013100342095A CN 201310034209 A CN201310034209 A CN 201310034209A CN 103073636 A CN103073636 A CN 103073636A
Authority
CN
China
Prior art keywords
der
dust mite
seq
gly
allergen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013100342095A
Other languages
Chinese (zh)
Inventor
赖仞
安输
容明强
李东升
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming Institute of Zoology of CAS
Original Assignee
Kunming Institute of Zoology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming Institute of Zoology of CAS filed Critical Kunming Institute of Zoology of CAS
Priority to CN2013100342095A priority Critical patent/CN103073636A/en
Publication of CN103073636A publication Critical patent/CN103073636A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications of the Der f 29 and the Der f 30, and belongs to the technical field of biomedicine. The Der f 29 and the Der f 30 are formed by amino acid sequences as shown in SEQ ID NO:1 (sequence identification number:1) and SEQ ID NO:3 respectively. The genes coding the Der f 29 and the Der f 30 are formed by nucleotide sequences as shown in SEQ ID NO:2 and SEQ ID NO:4 respectively. The Der f 29 and the Der f 30 are applied in preparing a medicine for treating a dermtophagoides farinae anaphylactic disease. The Der f 29 and the Der f 30 and the genes of the Der f 29 and the Der f 30 are provided, so that the Der f 29 and the Der f 30 can be applied in preparing the medicine for treating the dermtophagoides farinae anaphylactic disease.

Description

Dust mite allergen Derf29 and Derf30 and gene thereof and application
Technical field:
The present invention relates to a kind of dust mite allergen Der f 29 and Der f 30 and gene and application, belong to field of biomedicine technology.
Background technology:
Anaphylactic disease (as asthma, allergic rhinitis etc.) is common disease, frequently-occurring disease clinically, the total incidence of countries in the world anaphylactic disease is up to 10-30%, it is the great hygienic problems of our times, China has asthmatic patient more than 2,000 ten thousand now at present, Allergic Rhinitis more than 5,000 ten thousand, and its M & M is still in rising trend, recent two decades comes sickness rate almost to turn over one times.In causing numerous inhalant allergens of anaphylactic disease, the dirt mite is the most important factor that causes the allergic airway disease disease.Since Voorhorst and Spieksma(1964) confirm that first dirt mite and meta-bolites are the main allergen in room dirt since, countries in the world (American-European countries, Japan, China etc.) allergology worker also unanimously confirms that by a large amount of investigation the dirt mite is global main allergen.The dirt mite is the about 70-80% of positive rate in the immunodiagnosis of anaphylactic disease patient-specific.Since Noon and Freeman(1911) since first Application thimothy grass Pollen allergenic extract (allergen extract) is used for the treatment of pollinosis, desensitization treatment is the history of existing more than 90 year so far.Along with the further understanding to the pathogenetic further investigation of allergic disease and immunotherapy mechanism, WHO(1997) suggestion renames as allergen vaccine (allergen vaccine) by allergenic extract, and points out in " policy paper of the relevant immunotherapy of WHO " (1998): (1) encourages the standardized allergen vaccine of application and development; (2) high-quality allergen vaccine is depended in successful immunotherapy.Therefore, develop the efficient allergen vaccine of a new generation and be still this area research focus both at home and abroad.
Because the dirt mite is the medical science arthropods, structure and complicated, although at present people in the hundreds of albumen of dirt mite preliminary evaluation go out 16 kinds of anaphylactogen compositions, studies show that the anaphylactogen that the dirt mite contains nearly more than 30 plants.With regard to some dust mite allergy patients, he may only produce anaphylaxis to the class in the dirt mite or number class allergen protein.And for dust mite allergy patient diagnosis and desensitization treatment, be at present still the thick immersion liquid of dirt mite clinically, wherein contain in a large number the non-specific anaphylactogen of patient and other impurity, this has seriously hindered the standardized formulation of dust mite allergy original reagent and use clinically thereof.So further verify the definite component of dust mite allergen, will bring for the dust mite allergy patient desensitization treatment of individuation.
Summary of the invention:
The object of the present invention is to provide a kind of dust mite allergen Der f 29 and Der f 30 and gene and application.
Technical scheme of the present invention is as follows:
Der f 29 is our separation and purification obtains from the homogenate of dirt mite first a kind of new allergen proteins, and it belongs to a class Peptidyl-prolyl cis-trans isomerase protein family, the about 15kDa of molecular weight.Der f 29 is comprised of 164 amino acid, its aminoacid sequence following (SEQ ID NO:1):
MALPRVFFDIAADNQPLGRIVIELRSDVVPKTAENFRALCTGEKGFGFKSSSFHRIIPNF 60
MIQGGDFTNHNGTGGKSIYGNKFADENFTLQHTGPGIMSMANAGPNTNGSQFFITTVKTT 120
WLDGKHVVFGSVVEGMDIVKKVESYGSQSGKPSKKVTIANCGQL 164
Dust mite allergen Der f 29 gene clone steps comprise: the total RNA of dirt mite extracts, the mRNA purifying, and mRNA reverse transcription and cDNA library build, and the design primer, utilize PCR method amplification coding gene.The gene sequencing result shows that the encoding gene (GenBank accession AY283280.1) of dust mite allergen Der f 29 is comprised of 495 Nucleotide, and 5 ' end to 3 ' terminal sequence of this gene is (nucleotides sequence is classified SEQ ID NO:2 as):
atggcacttc ctcgtgtttt tttcgatatt gctgccgata atcaaccatt gggtcgtatt 60
gtcattgagc tccgtagtga tgttgtgccc aaaacagcgg aaaatttccg tgcactttgc 120
actggtgaaa aaggatttgg ttttaaatca tcctcatttc atcgtatcat acccaatttt 180
atgatccaag gcggtgattt cactaaccat aatggtactg gtggtaaatc catctatggt 240
aacaaatttg ccgatgaaaa tttcacactt caacacaccg gacctggtat catgtccatg 300
gcaaatgccg gtccaaacac caatggttca cagtttttca ttacaaccgt aaagactacc 360
tggttggatg gcaaacacgt tgtttttggt tcggttgtcg aaggaatgga cattgtaaaa 420
aaggtggaaa gctatggctc acaatcgggt aaaccatcca agaaagtgac cattgctaat 480
tgtggtcagc tttaa 495
Der f 30 belongs to iron-binding protein family (Ferritin), and molecular weight is 15 kDa approximately.Der f 30 is comprised of 171 amino acid, its aminoacid sequence following (SEQ ID NO:3):
MAANPESTTKTSRVRMNIQINLEFYASYVYQQMAYHFNRDDVALPGFEKFFDVSSKEERE 60
HAERFMKLQNQRGGRIVLDDIHKPQQQDWSSGLEAMRAALELEKTVNQALLDLHAVATKH 120
NDAQFADFIETHYLTEQVEAIKKLADYITNLERCGPGLGEYLFDRHTLHSS 171
Dust mite allergen Der f 30 gene clone steps comprise: the total RNA of dirt mite extracts, the mRNA purifying, and mRNA reverse transcription and cDNA library build, and the design primer, utilize PCR method amplification coding gene.The gene sequencing result shows that the encoding gene (GenBank accession KC305503) of dust mite allergen Der f 30 is comprised of 516 Nucleotide, and 5 ' end to 3 ' terminal sequence of this gene is (nucleotides sequence is classified SEQ ID NO:4 as):
atggctgcta atcctgaatc aacaaccaaa acttcacgtg tacgaatgaa tattcaaatt 60
aatttggagt tctatgcatc ctatgtatat caacagatgg cctatcattt taatcgtgat 120
gatgttgcat tgcctggttt tgaaaaattt ttcgatgtat catccaaaga agaacgtgaa 180
cacgctgaac gttttatgaa attacagaat caacgtggtg gacgtattgt attggatgat 240
attcataaac cgcaacaaca agattggtca tcaggattgg aagcaatgcg tgctgcattg 300
gaattggaaa aaacagtcaa tcaggcattg ttggatttgc atgccgttgc caccaaacac 360
aatgatgcac aatttgctga ttttattgaa acacattatc taactgaaca agtggaagcc 420
atcaagaaat tggctgatta tattaccaat ttggaacgtt gtggccccgg acttggtgaa 480
tatctttttg atcgtcatac attgcattca tcgtaa 516
Western blot detects discovery, and from 41 parts of dust mite allergy patients serums, Der f 29 is positive with wherein 35 parts, and the positive reaction rate is 85.6%; Der f 30 is positive with wherein 26 parts, and the positive reaction rate is 63.4%.Elisa detects discovery, and positive group of absorption value at the 450nm place of Der f 29 and Der f 30 is respectively 4.6 and 5.1 times of negative control group.Clinical skin acupuncture experiment shows, for 10 dust mite allergy patients, Der f 29 is positive with the skin acupuncture experiment of 7 wherein, and the positive reaction rate is 70%; Der f 30 is positive with the skin acupuncture experiment of 6 wherein, and the positive reaction rate is 60%.In the basophilic cell activation experiment, the percentage that Der f 29 acts on CD63 that dust mite allergy patient peripheral blood basophilic cell induces and the two positive cells of CCR3 is approximately 7.1 times of negative control group; The percentage that Der f 30 acts on CD63 that dust mite allergy patient peripheral blood basophilic cell induces and the two positive cells of CCR3 is approximately 5.9 times of negative control group.
Above-mentioned anaphylactogen detects to be found, Der f 29 and Der f 30 have stronger allergenicity, are the main allergens from the dirt mite, can be as the application of preparation treatment dust mite allergy disease medicament.
Beneficial effect of the present invention is: dust mite allergy Der f 29 and Der f 30 and gene thereof are provided, and dust mite allergen Der f 29 and Der f 30 can be as the application of preparation treatment dust mite allergy disease medicament.
The accompanying drawing explanation:
Fig. 1-A is the peak type figure that molecular sieve Sephadex-G75 is crossed in the homogenate of dirt mite.
Fig. 1-B is that dirt mite homogenate molecular sieve Sephadex-G75 III peak is after the peak of anion-exchange column Resource Q type figure.
Fig. 1-C is peak type figure and the electrophorogram that Der f 29 crosses Resource Q.
Fig. 1-D is peak type figure and the electrophorogram that Der f 30 crosses Resource Q.
Fig. 2-A is Der f 29 and wherein 9 dust mite allergy patients serums and 1 negative control Western blot result.
Fig. 2-B is Der f 30 and wherein 9 dust mite allergy patients serums and 1 negative control Western blot result.
Fig. 2-C is the Elisa result of Der f 29 and dust mite allergy patients serum IgE effect, wherein organizes 1 use serum from Healthy People, as negative control, organizes 2 serum used from the dust mite allergy patient.
Fig. 2-D is the Elisa result of Der f 29 and dust mite allergy patients serum IgE effect, wherein organizes 1 serum used from Healthy People, as negative control, organizes 2 serum used from the dust mite allergy patient.
Fig. 3-A to Fig. 3-D is the basophilic cell activation results of Der f 29.Wherein:
Fig. 3-A basophilic cell used, from Der f 29 irritated patients' peripheral blood, is organized 1 and with Der f 29 activation, is not used as negative control; Fig. 3-B basophilic cell used is from the peripheral blood of Healthy People, and organizing 1 is also with Der f 29 activation, not to be used as negative control; Fig. 3-C basophilic cell used is from Der f 30 irritated patients' peripheral blood, group 1 is not used as negative control with Der f 30 activation, Fig. 3-D basophilic cell used is from the peripheral blood of Healthy People, and organizing 1 is also with Der f 30 activation, not to be used as negative control.
The Western blot figure that Fig. 4-A is dirt mite homogenate Sephadex-G75 III peak, its mid point 1 is Der f 29.
The Western blot figure that Fig. 4-B is dirt mite homogenate Sephadex-G75 III peak, its mid point 1 is Der f 30.
Embodiment:
Embodiment mono-: the evaluation of dust mite allergen and determined amino acid sequence thereof
One, the preparation of the raising of dirt mite and collection and the homogenate of dirt mite
The dust mite of pure strain is carried out to batch as for the mouse grain that adopts the grinds powder under the condition of 25 ℃ of relative humidity 75% raises.Because the dirt mite has the life characteristic of lucifuge, the available incandescent lamp luminescence method is separated the dirt mite from feed.For the dirt mite separated, can add appropriate 20mM pH 7.8 Tris-HCL fully to grind, then at centrifugal 30 min of rotating speed 12000 * g, obtain supernatant.
Two, the separation and purification of dust mite allergen
The supernatant liquor of above-mentioned collection of take is raw material, is splined on and uses in advance the good molecular sieve gel chromatography Sephadex-G75 of 20mM pH7.8 Tris-HCL damping fluid balance, with identical damping fluid, carries out wash-out.Flow velocity is 0.3ml/min, with the every 10min of automatic collector, collects a pipe, detects the absorption value of every pipe at 280nm and 215nm place, makes the peak type figure of absorption value variation as shown in Figure 1A.Then every peak is collected to freeze-drying and concentrated separation and purification or two-dimensional electrophoresis and the Western blot detection thereof for next step.
To continue anion-exchange column Resource Q from molecular sieve gel chromatography Sephadex-G75 III peak, peak type figure is as shown in Fig. 1-B, 2 peaks in Figure 1B continued the peak type figure of Resource Q again as shown in Fig. 1-C and Fig. 1-D, and what insert is Der f 29 and Der f 30 electrophorograms.
Three, two-dimensional electrophoresis and Western blot thereof detect
Two-dimensional electrophoresis and Western blot concrete steps thereof are as follows:
A. sample preparation: adopt the 2D clean-up of GE company the sample from each peak of molecular sieve to be carried out to the processing such as desalination and concentration, main process is as follows:
1: in will the micro centrifugal pipe of sample as for 1.5 ml containing the 60 μ g 100 μ l that have an appointment, add 300 μ l precipitation agents vibrations to stir evenly, ice bath 15 min.
2: with centrifugal 5 min of maximum speed of revolution (12000 * g), get clean supernatant as far as possible.Add 40 μ l coprecipitators, ice bath 5 min.Centrifugal 5 min of same rotational speed, remove supernatant with liquid-transfering gun again, adds 25 μ l to add 1 ml lavation buffer solution (-20 ℃ of at least precoolings 1 hour) and 5 μ l detergent additives, vibration until precipitation scatter fully.Pipe is hatched under-20 ℃ at least 30 min, every 10 min vibration 20 to 30 s.
3: with centrifugal 5 min of rotating speed 12000 * g.
4: carefully supernatant is removed, now visible white precipitate, will precipitate simply air-dry.
5: add 150 μ l hydrating fluids dissolution precipitation again, use to isoelectric focusing electrophoresis (IEF) in order to first.
B. isoelectrofocusing (IEF): will be splined on the non-linear adhesive tape of the long Immobiline DryStrip of 7 cm containing the 60 μ g sample 100 μ l hydrating fluids of having an appointment, on Ettan IPGphor III isoelectrofocusing system, focus on, the isoelectrofocusing condition is 20 ℃, the electric current of every glue is 50 μ A, and gross focusing volt hour is about 6 kVh.The adhesive tape that isoelectrofocusing is good is respectively washed 15 min with the balance liquid that contains dithiothreitol (DTT) (DTT) and iodo-acid amide respectively, on the SDS-PAGE glue face that the concentration that good adhesive tape is disposed across to prepare by balance is 12%, and seals with agarose, prepares second to electrophoresis.
C. second to electrophoresis: for the glue width, only have the blob of viscose of 7 cm to be run glue with SE260.In the condition of 20 mA/ glue, get final product next half an hour.
D. the Western blot of two-dimensional electrophoresis: need to run two two-dimensional electrophoresis for same sample, wherein one for substantive dyeing, one is then used in Western blot, detailed process is as follows:
1: transferring film: the albumen on 2-D-SDS-PAGE glue is gone on pvdf membrane under the condition of 200 mA 2 h with the transferring film groove.
2: sealing: will turn the pvdf membrane that albumen is arranged and seal 2h with 5% skim-milk at normal temperature.
3: primary antibodie is hatched: the pvdf membrane sealed is washed with PBS, primary antibodie (dust mite allergy patients serum) is pressed to the 1:20 dilution with 5% skim-milk, 4 ℃ of overnight incubation.
4: two anti-hatching: the pvdf membrane that primary antibodie is hatched with the PBS washing, is pressed the 1:2000 dilution to two anti-(sheep anti human IgEs) with 5% skim-milk again, at normal temperature, hatches 1 hour.
5: develop: by two PBS washings 3 times for anti-pvdf membrane of hatching, each 5 min, add two appropriate anti-special luminous substrate on the film surface, with film, developed.
E. will mate 2-D-PAGE protein site preferably with development point on film and carry out the order-checking of ESI-Q-TOF mass spectrum.
Embodiment bis-: the gene clone of dust mite allergen
One, the total RNA of dirt mite extracts
A. take the approximately dirt mite alive of 80 mg, add 1 mL Trizol extracting solution (American I nvitrogen company) of precooling, and add the abundant homogenate of liquid nitrogen.
B. the chloroform that adds Trizol 1/5 volume, acutely mix approximately 15 seconds, and room temperature is placed 5 minutes, and 4 ℃, centrifugal 10 minutes of 12000 rpm, get supernatant.
C. supernatant adds isopyknic Virahol, and room temperature is placed 10 minutes, and 4 ℃, centrifugal 10 minutes of 12000 rpm, precipitation is washed once with 75% ethanol, dries, and pipe end throw out is the total RNA of intestines in the Eupolyphaga Seu Steleophaga digestive tube.
Two, the purifying of dirt mite mRNA
Dirt mite mRNA separation and purification adopts the PolyATtract of U.S. PROMEGA company mRNA Isolation Systems test kit.
A. get the total RNA 500 μ g of dirt mite and be dissolved in 500 μ L DEPC water, 65 ℃ of water-bath 10 min, add Oligo (dT) probe and the 13 μ L 20 * SSC solution of people 3 μ L, mixes, and places room temperature cooling, is called A liquid.
B. the washing of magnetic bead (SA-PMP): magnetic bead is flicked and mixes, to magnetic frame absorption 30 seconds, abandon supernatant, add 0. 5 * SSC, 300 μ L, to magnetic frame absorption 30 seconds, finally add 100 μ L 0. 5 * SSC and suspend, be called B liquid.
C. A liquid is added in B liquid, room temperature was placed 10 min, to magnetic frame absorption 30 seconds, abandon supernatant, with 0. 1 * SSC washing 4 times, finally abandon supernatant, add 100 μ L DEPC aqueous suspensions, adsorb 30 s to magnetic frame, supernatant is moved to new test tube, then add 150 μ L DEPC water resuspended, adsorb 30 s to magnetic frame, move supernatant to above-mentioned test tube, be intestines mRNA in the Eupolyphaga Seu Steleophaga digestive tube of purifying.
D. the sodium acetate solution that adds pH5. 2,3 M of 1/10 volume, the equal-volume Virahol, in-70 ℃ of placements 30 minutes, 4 ℃, centrifugal 10 min of 12000 rpm, abandoned supernatant, is precipitated and dissolved in 10 μ L DEPC water.
Three, dirt mite cDNA library builds
Adopt the Creator of CLONTECH company tMsMART tMcDNA Library Construction Kit builds dirt mite cDNA library.
A. cDNA the first chain is synthetic
Add 2 μ l dirt mite mRNA, 1 μ l SMART IV primer, 1 μ l CDS III/3 ' PCR primer, 1 μ l RNA-free water in aseptic PCR pipe, make cumulative volume reach 5 μ l, mix also of short duration centrifugal.
1.72 ℃ insulation 2 min, hatch 2 min on ice.
2. add 2 μ l 5 * the first chain buffer, 1 μ l 20 mmol/L DTT, 1 μ l 10 mmol/L dNTP mixtures, 1 μ l PowerScript reversed transcriptive enzyme in above-mentioned PCR pipe, mix also of short duration centrifugal.
3., after being placed in 42 ℃ of insulation 1 hr of PCR instrument, ice bath stops the synthetic of the first chain.
B. adopt long end polymerase chain reaction (LD-PCR) method amplification cDNA the second chain
1. 1 μ l cDNA the first chain, 40 μ l deionized waters, 5 μ l 10 * Advantage 2 PCR damping fluids, 1 μ l 50 * dNTP mixture, 1 μ l 5 ' PCR primer, 1 μ l CDS III/3 ' PCR primer and 1 μ l polysaccharase are mixed in the PCR pipe.
2. in the PCR instrument, by following program, increase: 95 ℃, 20 sec; 22 circulations: 95 ℃, 5 sec; 68 ℃, 6 min.
3., after amplification finishes, synthetic double-stranded cDNA is placed in to-70 ℃ of preservations.
C. the conversion that enzyme is cut, connected and connects product:
1. add 1 μ L pMD19-T carrier (Japanese Takara company), the double-stranded solution of 4 μ L dirt mite cDNA in Eppendorf tube, full dose is 5 μ L.
2. add 5 μ L(equivalent) the ligase enzyme buffer mixture.
3. 16 ℃ are reacted 2 hours.
4. full dose (10 μ L) is added in 100 μ L DH5 α competent cells (sky, Beijing root biochemical technology company limited), ice bath 30 minutes.
5. after 42 ℃ of 90 seconds of heating, then in ice, place 1 minute.
6. add 37 ℃ of LB substratum 900 μ L of bathing of temperature, 37 ℃ of slow shaking culture 60 minutes.
7. get 200 μ L and coat on the LB substratum that contains X-Gal, IPTG, Amp 37 ℃ and cultivate 16 hours, form single bacterium colony.
8. 5 mL LB liquid nutrient medium washing bacterium colonies for each LB plate, add 30% glycerine frozen.The cDNA built is approximately containing 2 * 10 6individual independent clone.
Four, the amplification of dust mite allergen gene order and mensuration:
Aminoacid sequence according to separation and purification gained dust mite allergen Der f 29 in embodiment mono-, we have designed a degenerated primer Der f 29-F and Der f 30-F, joint primer CDS III/3 ' the PCR pairing of using when building intestines cDNA library in the Eupolyphaga Seu Steleophaga digestive tube, forward and reverse primer sequence is:
CDS III/3’ PCR:5’-ATTCTAGAGGCCGAGGCGGCCATG-3’。
Der f 29-F: 5’-ATGGC(A/T/C/G)CT(A/T/C/G)CC(A/T/C/G)AG(A/G)GT(A/T/C/G)
TT(T/C)TT(T/C) -3’。
Der f 30-F: 5’-ATGGC(A/T/C/G)GC(A/T/C/G)AA(T/C)CC(A/T/C/G)GA(A/G)
AG(T/C)AC(A/T/C/G) -3’。
Wherein, the base in bracket means degenerated primer.
Degenerated primer and joint primer CDS III/3 ' PCR pairing are used, and the dirt mite cDNA of take is template, carries out PCR.Its reaction conditions is: 95 ℃ of denaturation 4 min, then carry out 30 in following condition and take turns circulation, 94 ℃ of 30 sec, 55 ℃ of 30 sec, 72 ℃ of 40 sec, then 72 ℃ of 10 min.Then the PCR product is connected on the T carrier, imports bacillus coli DH 5 alpha, the screening mono-clonal is checked order.Result show the to encode cDNA sequence of allergen Der f 29 is comprised of 495 Nucleotide, and the cDNA sequence of allergen Der f 30 is comprised of 516 Nucleotide.
Embodiment tri-: the allergenicity of dust mite allergen Der f 29 detects
The dust mite allergen Der f 29 that separation and purification is obtained carries out following allergenicity detection.
One, Western blot experiment
The SDS-PAGE glue that the preparation gum concentration is 12%, at the reductive condition electrophoresis.After electrophoresis, utilize the transferring film groove that the Der f 29 on PAGE glue is gone to PVDF upper, the skim-milk with 5% seals 2 hr, and washings adds 4 ℃ of overnight incubation of primary antibodie (primary antibodie is Yao horsefly allergic disease human serum, presses the 1:80 dilution) after washing 3 times.Hatch 1 hr(bis-and resist for the sheep anti human IgE with adding two anti-normal temperature after washings washing 3 times), after again washing 3 times, available two anti-connected horseradish peroxidase substrates develop.
Two, Elisa experiment
With coating buffer, anaphylactogen is diluted to 10 μ g/ml, spends the night with 4 ℃ of 50 μ l are coated, the patients serum press the 1:50 dilution, two anti-be to dilute by 1:2000, finally survey the absorbance value of OD450 nm.
Three, competitive Elisa suppresses experiment
Detailed process: the dirt mite crude extract that is 50 μ g/ml by 50 μ l concentration is coated with 96 orifice plates, and primary antibodie is pressed the 1:30 dilution with 3% BSA, with final concentration, is then 30 to 3 * 10 respectively -4the crude extract of μ g/ml and the effect of anaphylactogen room temperature 1 hour, two anti-1:2000 dilution, the absorption values of detection OD450 of pressing.
Four, induce the basophilic cell activation experiment
Utilize the ficoll-hypaque method to separate the peripheral blood lymphocytes (PBMC) in the irritated patients blood of Der f 29, PBMC contains lymphocyte, monocyte and basophilic cell.Anaphylactogen and PBMC that the final concentration of take is 1 μ g/ml are hatched 30 min at 37 ℃, with 37 ℃ of antibody FITC-anti-CD63 and PE-anti-CD193 (CCR3), hatch 20 minutes after washing 3 times again, with flow cytometer, detect after washing 3 times.That wherein positive control is used is anti-IgE, and that negative control is used is wash buffer (cell PBS).The anti-CD193 of PE mark (CCR3) stably express on the basophilic cell film, it can be used as the marker of basophilic cell.On the streaming figure of PBMC, basophilic cell is positioned at lymphocyte and monocytic intersection, utilizes negative control and PE-anti-CD193 (CCR3) that this part cell is irised out (gating).The basophilic cell activation results can mean with the percentage of CD63 and the two positive basophilic cells of CCR3.
Five, skin acupuncture experiment
Drop in patient's forearm palmar skin with the anaphylactogen of physiological saline solution, by special pricking needles prick skin, a small amount of anaphylactogen is entered in skin, dry the anaphylactogen of leaving over, read result after 15 min, make feminine gender and positive control with physiological saline and histamine respectively.Der f 29 results are as table 1, and Der f 29 is as table 2.
29 couples of 10 dust mite allergy patients' of table 1:Der f skin acupuncture experimental result
Figure BDA0000279134971
30 couples of 10 dust mite allergy patients' of table 2:Der f skin acupuncture experimental result
Figure BDA0000279134972
SEQUENCE LISTING
<110 > Kunming Institute of Zoology, Chinese Academy of Sciences
<120 > dust mite allergen Der f 29 and Der f 30 and gene and application
<130> 1
<160> 4
<170> PatentIn version 3.3
<210> 1
<211> 164
<212> PRT
<213> Dermatophagoides farinae
<400> 1
Met Ala Leu Pro Arg Val Phe Phe Asp Ile Ala Ala Asp Asn Gln Pro
1 5 10 15
Leu Gly Arg Ile Val Ile Glu Leu Arg Ser Asp Val Val Pro Lys Thr
20 25 30
Ala Glu Asn Phe Arg Ala Leu Cys Thr Gly Glu Lys Gly Phe Gly Phe
35 40 45
Lys Ser Ser Ser Phe His Arg Ile Ile Pro Asn Phe Met Ile Gln Gly
50 55 60
Gly Asp Phe Thr Asn His Asn Gly Thr Gly Gly Lys Ser Ile Tyr Gly
65 70 75 80
Asn Lys Phe Ala Asp Glu Asn Phe Thr Leu Gln His Thr Gly Pro Gly
85 90 95
Ile Met Ser Met Ala Asn Ala Gly Pro Asn Thr Asn Gly Ser Gln Phe
100 105 110
Phe Ile Thr Thr Val Lys Thr Thr Trp Leu Asp Gly Lys His Val Val
115 120 125
Phe Gly Ser Val Val Glu Gly Met Asp Ile Val Lys Lys Val Glu Ser
130 135 140
Tyr Gly Ser Gln Ser Gly Lys Pro Ser Lys Lys Val Thr Ile Ala Asn
145 150 155 160
Cys Gly Gln Leu
<210> 2
<211> 495
<212> DNA
<213> Dermatophagoides farinae
<400> 2
atggcacttc ctcgtgtttt tttcgatatt gctgccgata atcaaccatt gggtcgtatt 60
gtcattgagc tccgtagtga tgttgtgccc aaaacagcgg aaaatttccg tgcactttgc 120
actggtgaaa aaggatttgg ttttaaatca tcctcatttc atcgtatcat acccaatttt 180
atgatccaag gcggtgattt cactaaccat aatggtactg gtggtaaatc catctatggt 240
aacaaatttg ccgatgaaaa tttcacactt caacacaccg gacctggtat catgtccatg 300
gcaaatgccg gtccaaacac caatggttca cagtttttca ttacaaccgt aaagactacc 360
tggttggatg gcaaacacgt tgtttttggt tcggttgtcg aaggaatgga cattgtaaaa 420
aaggtggaaa gctatggctc acaatcgggt aaaccatcca agaaagtgac cattgctaat 480
tgtggtcagc tttaa 495
<210> 3
<211> 171
<212> PRT
<213> Dermatophagoides farinae
<400> 3
Met Ala Ala Asn Pro Glu Ser Thr Thr Lys Thr Ser Arg Val Arg Met
1 5 10 15
Asn Ile Gln Ile Asn Leu Glu Phe Tyr Ala Ser Tyr Val Tyr Gln Gln
20 25 30
Met Ala Tyr His Phe Asn Arg Asp Asp Val Ala Leu Pro Gly Phe Glu
35 40 45
Lys Phe Phe Asp Val Ser Ser Lys Glu Glu Arg Glu His Ala Glu Arg
50 55 60
Phe Met Lys Leu Gln Asn Gln Arg Gly Gly Arg Ile Val Leu Asp Asp
65 70 75 80
Ile His Lys Pro Gln Gln Gln Asp Trp Ser Ser Gly Leu Glu Ala Met
85 90 95
Arg Ala Ala Leu Glu Leu Glu Lys Thr Val Asn Gln Ala Leu Leu Asp
100 105 110
Leu His Ala Val Ala Thr Lys His Asn Asp Ala Gln Phe Ala Asp Phe
115 120 125
Ile Glu Thr His Tyr Leu Thr Glu Gln Val Glu Ala Ile Lys Lys Leu
130 135 140
Ala Asp Tyr Ile Thr Asn Leu Glu Arg Cys Gly Pro Gly Leu Gly Glu
145 150 155 160
Tyr Leu Phe Asp Arg His Thr Leu His Ser Ser
165 170
<210> 4
<211> 516
<212> DNA
<213> Dermatophagoides farinae
<400> 4
atggctgcta atcctgaatc aacaaccaaa acttcacgtg tacgaatgaa tattcaaatt 60
aatttggagt tctatgcatc ctatgtatat caacagatgg cctatcattt taatcgtgat 120
gatgttgcat tgcctggttt tgaaaaattt ttcgatgtat catccaaaga agaacgtgaa 180
cacgctgaac gttttatgaa attacagaat caacgtggtg gacgtattgt attggatgat 240
attcataaac cgcaacaaca agattggtca tcaggattgg aagcaatgcg tgctgcattg 300
gaattggaaa aaacagtcaa tcaggcattg ttggatttgc atgccgttgc caccaaacac 360
aatgatgcac aatttgctga ttttattgaa acacattatc taactgaaca agtggaagcc 420
atcaagaaat tggctgatta tattaccaat ttggaacgtt gtggccccgg acttggtgaa 480
tatctttttg atcgtcatac attgcattca tcgtaa 516

Claims (3)

  1. Dust mite allergen Der f 29 and Der f 30, it is characterized in that by the aminoacid sequence shown in SEQ ID NO:1 and SEQ ID NO:3, being formed respectively.
  2. 2. the gene of coding dust mite allergen Der f 29 and Der f 30, is characterized in that the nucleotide sequence shown in SEQ ID NO:2 and SEQ ID NO:4, consisting of respectively.
  3. 3. dust mite allergen Der f 29 claimed in claim 1 and Der f 30 application in preparation treatment dust mite allergy disease medicament.
CN2013100342095A 2013-01-29 2013-01-29 Dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications thereof Pending CN103073636A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013100342095A CN103073636A (en) 2013-01-29 2013-01-29 Dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013100342095A CN103073636A (en) 2013-01-29 2013-01-29 Dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications thereof

Publications (1)

Publication Number Publication Date
CN103073636A true CN103073636A (en) 2013-05-01

Family

ID=48150352

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013100342095A Pending CN103073636A (en) 2013-01-29 2013-01-29 Dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications thereof

Country Status (1)

Country Link
CN (1) CN103073636A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108840917A (en) * 2018-06-12 2018-11-20 刘志刚 Dermatophagoides pteronyssinus allergen Der p 30 and its preparation method and application
CN108892716A (en) * 2018-06-12 2018-11-27 刘志刚 Dermatophagoides pteronyssinus allergen Der p 29 and its preparation method and application

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AN,S: "Dermatophagoides farinae allergen", 《GENBANK AGC56219》 *
CHEW, F.T等: "Der f Mal f 6 allergen [Dermatophagoides farinae]", 《GENBANK AAP35065》 *
刘志刚等: "粉尘螨抗细菌活性物质的分离与鉴定", 《江西师范大学学报(自然科学版)》 *
赵仕勇: "尘螨过敏原的分子生物学研究概况", 《实用儿科临床杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108840917A (en) * 2018-06-12 2018-11-20 刘志刚 Dermatophagoides pteronyssinus allergen Der p 30 and its preparation method and application
CN108892716A (en) * 2018-06-12 2018-11-27 刘志刚 Dermatophagoides pteronyssinus allergen Der p 29 and its preparation method and application
CN108840917B (en) * 2018-06-12 2021-11-12 刘志刚 House dust mite allergen Der p30 and preparation method and application thereof

Similar Documents

Publication Publication Date Title
DK165412B (en) METHOD OF MANUFACTURING HUMANT INTERLEUKIN
CN103421113A (en) Anti-BLyS antibody
CN110655556B (en) Preparation and method of immunoregulatory peptide
CN106967696A (en) A kind of anaphylactogen of Artemisia Plant Pollen and its application
CN102190708B (en) Barrel-shaped alpha conantokin Bt1.3 and application thereof
CN110090295A (en) Purposes of the Ephrin-B1 in the drug of preparation treatment inflammatory bowel disease
CN103073636A (en) Dermtophagoides farinae allergens Der f 29 and Der f 30, and genes and applications thereof
CN102307894B (en) A variant of mite allergen and uses thereof
CN103059119A (en) Dust mite allergen Derf28 and genes and application thereof
CN102071184B (en) Tabanusyao Macquart antithrombotic enzyme tablysin and gene and application thereof
CN103214565A (en) Dust mite allergens Derf24 and Derf25, and genes and applications thereof
CN102030822A (en) New human cell factor VSTM1-v2 and application thereof
CN110201188A (en) A kind of summer cypress pollen allergen extract, its leaching liquor and preparation method thereof
KR20040004481A (en) Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor
CN1450087A (en) Recombinant Toxoplasma fusion protein antigen and preparation process and use thereof
KR102007587B1 (en) Novel dermatophagoides farinae protein
CN103215236A (en) Dust mite allergens Derf8 and Derf20, and genes and applications thereof
CN103059120A (en) Dust mite allergens Derf26 and Derf27 and genes and application thereof
CN104558145A (en) Preparation methods for fetuin A recombinant protein and polyclonal antibody
CN109771641B (en) Sabina chinensis pollen allergen extract, extract and preparation method thereof
JP3707817B2 (en) Cypress pollen allergen
CN110124028A (en) A kind of pollen humuli scandentis allergen extract, immersion liquid and preparation method thereof
CN103705920B (en) Kytoplasm Polyadenylation component binding protein 4 vaccine and Synthesis and applications thereof
CN114685636B (en) Artemisia plant pollen allergen, application and kit
JPWO2012105541A1 (en) New cypress pollen allergen

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130501